Global hepatitis, migration and its impact on Western healthcare

Gut

Volumn 59, Issue 8, 2010, Pages 1009-1011

  Ahmed, Furqaan ^a   Foster, Graham R ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; HEALTH CARE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEPATITIS; HUMAN; IMMIGRATION; MIGRATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAFETY; SCREENING; VACCINATION;

DELIVERY OF HEALTH CARE; EMIGRATION AND IMMIGRATION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS;

EID: 77954724431     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.206763     Document Type: Review

References (24)

1. World Health Organization. Hepatitis B fact sheet. http://www.who.int/ mediacentre/factsheets/fs204/en/index.html.
2. World Health Organization. Hepatitis C. Geneva: WHO, 2002. http://www.who.int/entity/csr/disease/hepatitis/whocdscsrlyo2003/en/index.html.
3. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1992 through 2002. Ann Intern Med 2006;144:705-14.
4. Frank C, Mohammad MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C in Egypt. Lancet 2000;355:887-91. (Pubitemid 30137669)
5. Mostafa A, Taylor SM, El-Daly M. Is the hepatitis C epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int 2010;30:560-6.
6. Saleh DA, Shebl FM, AL-Kamary SS, et al. Incidence and risk factors for community acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Trans R Soc Trop Med Hyg 2010;104:357-63.
7. Hepatitis B Foundation UK. Rising curve: chronic hepatitis B infection in the UK 2007.
8. Monge-Maillo B, Jimenez BC, Perez-Molina JA. Imported infectious diseases in mobile populations, Spain. Emerg Infect Dis 2009;15:1745-52.
9. Hemminki K, Mousavi SM, Brandt A, et al. Liver and gallbladder cancer in immigrants to Sweden. Eur J Cancer 2010;46:926-31.
10. Mann AG, Trotter CL, Balogun MA, et al. Hepatitis C in ethnic minority populations in England. J Viral Hepat 2008;15:421-6.
11. Uddin G, Shoeb D, Solaiman S, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat 2010;17:327-35.
12. Wong JB, McQuillan GM, McHutchison JG, et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-9.
13. Buti M, San Miguel R, Brosa M, et al. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C. J Hepatol 2005;42:639-45.
14. Migrant Clinicians Network. Hepatitis screening, immunization and testing for mobile populations and immigrants from Mexico, Central and South America, and the Caribbean 2008.
15. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: Immunization of Adults. MMWR 2006:1-25.
16. Bock HL, Löscher T, Scheiermann N, et al. Accelerated schedule for hepatitis B immunization. J Travel Med 1995;2:213-17.
17. Mitchell AE, Colvin HM, Beasley RP. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 2010;51:729-33.
18. World Health Organization. Viral hepatitis. Report by the Secretariat. Geneva: WHO, 2009. EB126/15.
19. World Health Organization. Global Burden of disease survey. Geneva: WHO, 2000.
20. WHO Global Database on Blood Safety (GDBS) and Blood Safety Indicators.
21. Liu S, Fiueroa P, Rou K. Safety of the blood supply in a rural area of China. J Acquir Immune Defic Syndr 2010;53(suppl 1):s23-6.
22. Luby S, Khanani R, Zia M, et al. Evaluation of blood bank practices in Karachi, Pakistan and the government's response. Health Policy Plan 2000;15:217-22.
23. Resolutions WHA28.72 on utilization and supply of human blood and blood products.
24. Resolution WHA53.18 on quality of care: patient safety.